HOMCY CHARLES J
Insider CIK 1192591 · PTLA Director · MYOK Director · GBT Director · BBIO Chairman of Pharmaceuticals, Director · PLRX Director · PHIC Director · MAZE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2026-06-22 | 2026-06-24 | 5,277 | — | $0 | 5,277 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2026-06-22 | 2026-06-24 | 3,990 | — | $0 | 919,876 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2026-06-20 | 2026-06-23 | 788 | $66.27 | $52.2K | 915,886 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | A Award deriv | 2026-06-08 | 2026-06-10 | 18,000 | — | $0 | 18,000 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | G Gift | 2026-05-04 | 2026-05-06 | 7,422 | — | $0 | 31,113 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | J Other | 2025-11-19 | 2025-11-21 | 1,489 | — | $0 | 31,113 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | G Gift | 2025-10-23 | 2025-10-27 | 28,423 | — | $0 | 29,624 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | A Award deriv | 2025-09-22 | 2025-09-24 | 18,000 | — | $0 | 18,000 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-08-11 | 2025-08-12 | 50,000 | $48.00 | $2.40M | 916,674 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-08-08 | 2025-08-12 | 191,662 | $45.87 | $8.79M | 1,025,012 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-08-08 | 2025-08-12 | 58,338 | $46.64 | $2.72M | 966,674 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | G Gift | 2025-06-27 | 2025-06-30 | 20,000 | — | $0 | 1,216,674 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2025-06-20 | 2025-06-24 | 8,425 | — | $0 | 8,425 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2025-06-20 | 2025-06-24 | 6,589 | — | $0 | 1,236,674 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-04 | 71,564 | — | $0 | 0 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-04 | 169,405 | — | $0 | 0 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-04 | 72,727 | — | $0 | 0 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion | 2025-02-03 | 2025-02-04 | 8,807 | — | $0 | 37,330 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion | 2025-02-03 | 2025-02-04 | 20,717 | — | $0 | 58,047 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion | 2025-02-03 | 2025-02-04 | 7,422 | — | $0 | 7,422 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | A Award deriv | 2024-12-09 | 2025-02-04 | 0 | — | $0 | 0 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | D To issuer deriv | 2024-12-09 | 2025-02-04 | 45,638 | — | $0 | 45,638 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | A Award deriv | 2024-12-09 | 2025-02-04 | 46,675 | — | $0 | 0 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | A Award deriv | 2024-12-09 | 2025-02-04 | 80,385 | — | $0 | 0 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | D To issuer deriv | 2024-12-09 | 2025-02-04 | 5,704 | — | $0 | 5,704 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | D To issuer deriv | 2024-12-09 | 2025-02-04 | 46,675 | — | $0 | 46,675 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | A Award deriv | 2024-12-09 | 2025-02-04 | 5,704 | — | $0 | 0 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion deriv | 2024-11-26 | 2025-02-04 | 71,564 | — | $0 | 7,422 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion deriv | 2024-11-26 | 2025-02-04 | 80,385 | $78961.64 | $6.35B | 80,385 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2024-06-21 | 2024-06-25 | 26,014 | — | $0 | 26,014 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-02-16 | 2024-02-21 | 3,760 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2024-02-16 | 2024-02-21 | 3,760 | — | $0 | 1,231,594 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2024-02-16 | 2024-02-21 | 1,509 | $37.21 | $56.1K | 1,230,085 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-11-16 | 2023-11-20 | 3,760 | — | $0 | 3,760 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2023-11-16 | 2023-11-20 | 1,301 | $28.86 | $37.5K | 1,226,996 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2023-11-16 | 2023-11-20 | 3,760 | — | $0 | 1,228,297 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-08-16 | 2023-08-18 | 3,760 | — | $0 | 7,520 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2023-08-16 | 2023-08-18 | 3,760 | — | $0 | 1,225,838 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2023-08-16 | 2023-08-18 | 1,301 | $29.80 | $38.8K | 1,224,537 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2023-06-21 | 2023-06-23 | 51,501 | — | $0 | 51,501 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-05-16 | 2023-05-18 | 3,759 | — | $0 | 11,280 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2023-05-16 | 2023-05-18 | 1,300 | $14.09 | $18.3K | 1,220,827 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2023-05-16 | 2023-05-18 | 3,759 | — | $0 | 1,222,127 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-02-16 | 2023-02-21 | 3,760 | — | $0 | 15,039 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2023-02-16 | 2023-02-21 | 3,760 | — | $0 | 1,219,902 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2023-02-16 | 2023-02-21 | 1,534 | $12.64 | $19.4K | 1,218,368 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-11-16 | 2022-11-18 | 3,760 | — | $0 | 18,799 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2022-11-16 | 2022-11-18 | 3,760 | — | $0 | 1,215,552 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2022-11-16 | 2022-11-18 | 1,301 | $9.64 | $12.5K | 1,214,251 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-08-16 | 2022-08-18 | 3,760 | — | $0 | 22,559 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2022-08-16 | 2022-08-18 | 3,760 | — | $0 | 1,210,742 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2022-08-16 | 2022-08-18 | 1,287 | $11.08 | $14.3K | 1,209,455 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 104,921 | — | $0 | 104,921 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-05-16 | 2022-05-18 | 3,759 | — | $0 | 26,319 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2022-05-16 | 2022-05-18 | 1,541 | $6.74 | $10.4K | 1,206,982 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2022-05-16 | 2022-05-18 | 3,759 | — | $0 | 1,208,523 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2022-02-28 | 2022-03-15 | 30,078 | — | $0 | 30,078 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2021-12-02 | 2021-12-06 | 55,011 | — | $0 | 55,011 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2021-06-29 | 2021-06-30 | 13,286 | — | $0 | 13,286 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2021-06-17 | 2021-06-22 | 38,895 | — | $0 | 38,895 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2021-03-01 | 2021-03-03 | 524 | $71.91 | $37.7K | 1,204,764 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2021-03-01 | 2021-03-03 | 1,521 | — | $0 | 1,205,288 | SEC↗ |
| PHIC Population Health Investme | J Other deriv | 2021-01-26 | 2021-01-26 | 43,125 | $250.00 | $10.78M | 43,125 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-10-16 | 2020-10-19 | 10,256 | — | $0 | 260,207 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-10-16 | 2020-10-19 | 10,256 | $41.00 | $420.5K | 1,203,767 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-10-16 | 2020-10-19 | 10,256 | $17.00 | $174.4K | 1,214,023 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-09-30 | 2020-10-01 | 10,000 | — | $0 | 270,463 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-09-30 | 2020-10-01 | 10,000 | $38.00 | $380.0K | 1,203,767 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-09-30 | 2020-10-01 | 10,000 | $17.00 | $170.0K | 1,213,767 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-09-29 | 2020-09-29 | 18,200 | $37.50 | $682.5K | 1,203,767 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-09-25 | 2020-09-29 | 65,661 | $36.68 | $2.41M | 1,237,363 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-09-25 | 2020-09-29 | 15,396 | $37.47 | $576.9K | 1,221,967 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-06-02 | 2020-06-04 | 112,422 | — | $0 | 112,422 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | G Gift | 2020-04-03 | 2020-04-07 | 40,000 | — | $0 | 1,302,291 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-02-10 | 2020-02-12 | 20,000 | $36.00 | $720.0K | 1,342,291 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-01-14 | 2020-01-16 | 10,000 | — | $0 | 280,463 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-01-14 | 2020-01-16 | 10,000 | $35.00 | $350.0K | 1,362,291 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-01-14 | 2020-01-16 | 10,000 | $17.00 | $170.0K | 1,372,291 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2019-12-12 | 2019-12-16 | 82,878 | — | $0 | 82,878 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 418,016 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 66,729 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 406,723 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 290,476 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 132,317 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 47,165 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 66,729 | — | $0 | 246,211 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 132,317 | — | $0 | 179,482 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 406,723 | — | $0 | 652,934 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 418,016 | — | $0 | 1,070,950 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 290,476 | — | $0 | 1,361,426 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 47,165 | — | $0 | 47,165 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2019-03-28 | 2019-04-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2019-01-02 | 2019-01-04 | 14,835 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2019-01-02 | 2019-01-04 | 11,481 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2019-01-02 | 2019-01-04 | 19,607 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2019-01-02 | 2019-01-04 | 45,923 | $5.10 | $234.2K | 165,403 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2018-12-19 | 2018-12-19 | 25,782 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2018-12-19 | 2018-12-19 | 25,782 | $4.10 | $105.7K | 119,480 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2018-12-17 | 2018-12-19 | 24,390 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2018-12-17 | 2018-12-19 | 39,828 | — | $0 | 25,782 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2018-12-17 | 2018-12-19 | 64,218 | $4.10 | $263.3K | 176,689 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2018-12-17 | 2018-12-19 | 700 | $19.20 | $13.4K | 112,471 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2018-12-17 | 2018-12-19 | 63,518 | $18.60 | $1.18M | 113,171 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2018-11-14 | 2018-11-16 | 93,698 | — | $0 | 65,610 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2018-11-14 | 2018-11-16 | 93,698 | $4.10 | $384.2K | 93,698 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2018-06-20 | 2018-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2018-06-08 | 2018-06-08 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2018-06-08 | 2018-06-08 | 3,000 | — | $0 | 115,471 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-10-27 | 2017-10-27 | 15,600 | $34.09 | $531.8K | 67,728 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-10-26 | 2017-10-27 | 54,400 | $33.93 | $1.85M | 83,328 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-10-04 | 2017-10-05 | 0 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-10-04 | 2017-10-05 | 0 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-10-04 | 2017-10-05 | 0 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-10-04 | 2017-10-05 | 0 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-10-03 | 2017-10-05 | 0 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-10-03 | 2017-10-05 | 0 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2017-06-23 | 2017-06-27 | 120,803 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2017-06-23 | 2017-06-27 | 120,803 | $53.06 | $6.41M | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2017-06-23 | 2017-06-27 | 120,803 | $5.00 | $604.0K | 120,803 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-06-20 | 2017-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2017-06-16 | 2017-06-19 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2017-06-16 | 2017-06-19 | 3,000 | — | $0 | 3,000 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-06-02 | 2017-06-22 | 31,742 | $27.64 | $877.3K | 137,728 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-06-02 | 2017-06-22 | 49,959 | $26.92 | $1.34M | 169,470 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-06-01 | 2017-06-22 | 18,299 | $26.58 | $486.4K | 219,429 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2017-03-15 | 2017-03-16 | 50,000 | — | $0 | 120,803 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2017-03-15 | 2017-03-16 | 50,000 | $5.00 | $250.0K | 50,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2017-03-15 | 2017-03-16 | 50,000 | $40.06 | $2.00M | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 0 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 0 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2017-03-01 | 2017-03-03 | 25,000 | — | $0 | 170,803 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2017-03-01 | 2017-03-03 | 25,000 | $5.00 | $125.0K | 25,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2017-03-01 | 2017-03-03 | 25,000 | $37.50 | $937.5K | 0 | SEC↗ |
| MYOK MyoKardia Inc | J Other | 2016-11-29 | 2016-12-01 | 0 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2016-11-14 | 2016-11-16 | 0 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2016-11-14 | 2016-11-16 | 0 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | J Other | 2016-11-03 | 2016-11-07 | 0 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2016-06-17 | 2016-06-20 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2016-06-17 | 2016-06-20 | 3,000 | — | $0 | 3,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2016-06-16 | 2016-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2016-06-07 | 2016-06-09 | 11,000 | — | $0 | 11,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-09-18 | 2015-09-18 | 20,000 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-09-18 | 2015-09-18 | 20,067 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-09-18 | 2015-09-18 | 20,000 | $5.00 | $100.0K | 20,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-09-18 | 2015-09-18 | 20,000 | $57.50 | $1.15M | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-09-18 | 2015-09-18 | 20,067 | $55.00 | $1.10M | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-09-18 | 2015-09-18 | 20,067 | $3.30 | $66.2K | 20,067 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2015-08-11 | 2015-08-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-07-13 | 2015-07-14 | 50,000 | — | $0 | 20,067 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-07-13 | 2015-07-14 | 50,000 | $3.30 | $165.0K | 50,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-07-13 | 2015-07-14 | 50,000 | $48.00 | $2.40M | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-06-29 | 2015-06-29 | 100,000 | — | $0 | 70,067 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-06-29 | 2015-06-29 | 100,000 | $3.30 | $330.0K | 100,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-06-29 | 2015-06-29 | 200 | $44.92 | $9.0K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-06-29 | 2015-06-29 | 27,876 | $44.24 | $1.23M | 200 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-06-29 | 2015-06-29 | 71,924 | $43.60 | $3.14M | 28,076 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2015-06-16 | 2015-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-02-23 | 2015-02-23 | 20,000 | — | $0 | 190,067 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-02-23 | 2015-02-23 | 20,000 | $3.30 | $66.0K | 20,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-02-23 | 2015-02-23 | 20,000 | $40.00 | $800.0K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-02-17 | 2015-02-17 | 20,000 | — | $0 | 190,067 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-02-17 | 2015-02-17 | 20,000 | $3.30 | $66.0K | 20,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-02-17 | 2015-02-17 | 20,000 | $36.00 | $720.0K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-02-13 | 2015-02-13 | 20,000 | — | $0 | 210,067 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-02-13 | 2015-02-13 | 20,000 | $3.30 | $66.0K | 20,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-02-13 | 2015-02-13 | 20,000 | $34.05 | $681.0K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-01-28 | 2015-01-28 | 19,700 | — | $0 | 230,067 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-01-28 | 2015-01-28 | 19,700 | $3.30 | $65.0K | 19,700 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-01-28 | 2015-01-28 | 19,700 | $30.00 | $591.0K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-01-27 | 2015-01-27 | 300 | — | $0 | 249,767 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-01-27 | 2015-01-27 | 300 | $30.00 | $9.0K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-01-27 | 2015-01-27 | 300 | $3.30 | $990 | 300 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2014-06-27 | 2014-07-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | G Gift | 2014-06-18 | 2014-06-20 | 20,000 | — | $0 | 103,471 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2013-10-22 | 2013-10-23 | 95,962 | $23.75 | $2.28M | 123,471 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | G Gift | 2013-08-21 | 2013-10-23 | 25,000 | — | $0 | 219,433 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2013-06-05 | 2013-06-07 | 14,101 | — | $0 | 14,101 | SEC↗ |